KEAP1 and type 1 diabetes nephropathy: The beneficial effect of icariin in STZ-induced type 1 diabetic nephropathy seems to be causally related to the GPER-mediated p62-dependent Keap1 degradation and Nrf2 activation (Wang et al., 2020).